FIG. 4.
Patient HR‐QoL and caregiver burden with LCIG treatment as measured by change from baseline. P values indicate significant difference compared with baseline using a 1‐sample t test: P ≤ 0 .001 (***), and P ≤ 0.01 (**). BL, baseline; D, day; HR‐QoL, health‐related quality of life; LCIG, levodopa‐carbidopa intestinal gel; M, month; MCSI, Modified Caregiver Strain Index; PDQ‐8, 8‐item Parkinson's Disease Questionnaire.